Zhao, Fangyuan
Copley, Brenda
Niu, Qun
Liu, Fang
Johnson, Julie A.
Sutton, Thomas
Khramtsova, Galina
Sveen, Elisabeth
Yoshimatsu, Toshio F.
Zheng, Yonglan
Ibraheem, Abiola
Jaskowiak, Nora
Nanda, Rita
Fleming, Gini F.
Olopade, Olufunmilayo I.
Huo, Dezheng http://orcid.org/0000-0002-4041-1678
Funding for this research was provided by:
National Cancer Institute (P20 CA233307)
Breast Cancer Research Foundation
Susan G. Komen for the Cure (SAC110026)
Article History
Received: 17 August 2020
Accepted: 15 October 2020
First Online: 27 October 2020
Compliance with ethical standards
:
: Olufunmilayo I. Olopade is a cofounder at CancerIQ and serves on the Scientific Advisory Board for Tempus. The other authors declare that they have no conflict of interest.
: The study protocol was approved by Intuitional Review Board of the University of Chicago. All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.